Healthcare
Cathay to close latest small-cap fund in early 2023 on up to EUR 350m
Vehicle will target companies with EVs of EUR 40m-EUR 100m and has so far made six acquisitions
GENUI explores Labor Team W exit just a year after labs group buyout
Rothschild hired to assess options after Swiss asset attracted inbound interest from trade
Bridgepoint reviews options for Diaverum advised by Citi
Strategic review follows pulled IPO attempt for Swedish dialysis company in 2020
Holland exits Mauritskliniek in sale to PE-backed Corius
Sale of Dutch dermatology group comes nine months after regulator blocked sale to Triton's Bergman
The Bolt-Ons Digest – 16 September 2022
Unquote’s selection of the latest add-ons with A&M's Ayesa, BC Partners' Valtech, Advent's IRCA, EQT's IVC Evidensia and more
Access holds EUR 306m final close for second co-investment fund
Paris-headquartered GP surpassed its EUR 300m target for the fund, which plans to make 16 investments
Auctus sells PharmaLex to trade for EUR 1.28bn
Deal values German pharma services company at 18x EBITDA
Vitruvian starts fundraising for VIP V
New vehicle registered this month; presented to Los Angeles-based LPs
Ex-Silverfleet team regroups with DACH-focused GP Sophora
Newly formed GP is raising capital from its own network with a longer-term goal of bringing in institutional investors
Magnum sells Miranza to PAI-backed Veonet for EUR 250m
Off-market deal values Spanish eye care chain at 14x EBITDA; at least three more ophtha assets in M&A pipeline
Investindustrial aims for EUR 1bn close with third lower-mid cap fund
Lower-mid market strategy has sealed one first investment ahead of expected closing in coming months
Duke Street to reap 2.5x-plus money in Medi-Globe sale to trade
DCC Healthcare to pay EUR 245m for German medical devices group; deal marks GP’s 12th trade exit
Trill Impact heads for first close of VC fund at year-end
Impact investor has a EUR 300m target for the debut VC fund; new vehicle has completed one deal so far
Verdane invests in Qbtech, Topro via impact fund
Privately-owned ADHD test maker and PE-backed mobility device producer are fourth and fifth deals from Verdane Idun I
C’est la rentrée: PEs line up French deals despite adverse market
Local economy managed to stay comparatively strong compared to sluggish global growth and inflationary pressures
Adelis exits Nordentic to PE-backed Corus
Sale leaves three assets in Adelis 2012 vintage fund; Corus backer CareVentures working on refi for acquisitions
Stirling Square cancels Outcomes First Group sale process
GP expected to switch focus to break-up of UK specialist care and fostering provider
Foresight reaps 4.1x on Mi Healthcare sale to trade
Exit of UK-based radiology machine services is fourth exit from North-West focused fund
Ampersand closes USD 1.2bn healthcare fund for US, EU deployment
Fundraise follows hiring push in Europe; GP typically deploys USD 10m-50m tickets in primary buyouts
Inflexion gears up for third Partnership Capital fund
GP’s previous vehicle dedicated to minority investing held a final close in 2018 on GBP 700m
Adelis raises continuation vehicle for SSI Diagnostica
New fund, with StepStone as lead investor, allows infectious test manufacturer to buy US peer TechLab
Advent, GHO could explore sale of intensive care providers in 12-18 months
Deutsche Fachpflege and Linimed expected to hit German auction pipeline; advisers yet to be appointed
The Bolt-Ons Digest - 19 August 2022
Unquote’s selection of the latest add-ons with Apax's Groupe Crystal, Livingbridge's CitNOW, Triton’s Fertiberia and more
Doxx owner pulls process despite solid bids from private equity players
Alantra-led sale process for the German healthcare staffing platform had lasted around six months
